Craig D. Boyle,Samuel Chackalamannil,Unmesh Shah,Jean E. Lachowicz
申请号：
US12498013
公开号：
US08389532B2
申请日:
2009.07.06
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The compound having the structural formula Ior a pharmaceutically acceptable salt thereof, is disclosed, as well as its use in the treatment of central nervous system diseases, in particular Parkinsons disease, Extra Pyramidal Syndrome, restless legs syndrome and attention deficit hyperactivity disorder, pharmaceutical compositions comprising it, and combinations with other agents.
